Yan Wang, Ph.D. (she/her/hers)

Staff Fellow
US Food and Drug Administration

Poster(s):

• (T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
  Tuesday, October 22, 2024

  9:30 AM – 10:30 AM MT

• (M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
  Monday, October 21, 2024

  10:30 AM – 11:30 AM MT

• (W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
  Wednesday, October 23, 2024

  11:30 AM – 12:30 PM MT

• (T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
  Tuesday, October 22, 2024

  1:30 PM – 2:30 PM MT

• (M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
  Monday, October 21, 2024

  2:30 PM – 3:30 PM MT

• (T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
  Tuesday, October 22, 2024

  3:30 PM – 4:30 PM MT